Early Physical Therapy Intervention in Preterm Infants

December 6, 2019 updated by: Mirari Ochandorena Acha, University of Vic - Central University of Catalonia

Early Physical Therapy Intervention in Preterm Infants During the Stay in the Neonatal Intensive Care Unit and at Home to Promote Motor Development

The hypothesis of this study is that early physical therapy intervention, initiated during the NICU stay and up to 2 months corrected age, based on the family-centered model, could promote preterm infants motor development in short-term (2 months corrected age) and long-term (8 months corrected age).

There is a high evidence level of different systematic reviews, which support the effectivity of early intervention with preterm infants.

The principal aim of this randomized controlled trial is to evaluate the effectiveness of early physiotherapy intervention to promote motor development in preterm infants at 2 and 8 months corrected age.

The secondary purpose is to study the motor development of those preterm infants who received early physical therapy intervention.

Study Overview

Study Type

Interventional

Enrollment (Actual)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain
        • Hospital Sant Joan de Deu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 7 months (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Preterm infants, gestational age between 28-34 weeks
  • Families with ability to take care of the child, without chronic or mental illness
  • Long-term parental presence in the hospital (at least 10h/day)

Exclusion Criteria:

  • Children diagnosed with congenital disease or brain injury (LPV, HIV), before or during the study
  • Children undergoing major surgery (cardiac intervention, Ductus, thoracic intervention)
  • Children with musculoskeletal deformities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Usual care Early physical therapy intervention at the UCIN and after discharge, at home; based on the family-centered model.

At the UCIN:

  • Parental education to empower them on motor development and parent-infant relationship. Consisted on 6 sessions during the first weeks at the NICU.
  • Tactile and kinaesthetic stimulation managed by parents. 2 times a day, 15 minutes each, during 10 days.

At home:

Psychomotor Development Program for the baby; comprised of different exercises, in different phases, depending on child maturation stage. Started after hospital discharge until 2 months corrected age.

Other: Control
Usual care
NICU usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motor development.
Time Frame: 2 months corrected age and 8 months corrected age
Assessed by the Alberta Infant Motor Scale (AIMS). Total maximum score 40 points. Higher values represent a better outcome.
2 months corrected age and 8 months corrected age

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Movement quality.
Time Frame: 40 weeks postmenstrual age and 2 months corrected age
Assessed by the General Movements Assessment. The assessment provide the quality of the movement (suboptimal/optimal/pathological).
40 weeks postmenstrual age and 2 months corrected age
Gross motor and fine motor function.
Time Frame: 8 months corrected age
Assessed by the Bayley Scale of Infant Development III. Percentile ranks from 1 to 99. Higher percentile represent a better outcome
8 months corrected age
Development and risk of development delay.
Time Frame: 1 months corrected age and 8 months corrected age
Assessed by the Ages and Stages Questionnaires Third Edition (ASQ-3). 30 questions covering 5 domains of development: communication, gross motor, fine motor, problem-solving and adaptive skills.
1 months corrected age and 8 months corrected age
Mothers' stress index.
Time Frame: after the intervention, 3 months corrected age
Assessed by the Parents Stress Index - Short Form. Composed of 36 items with a Likert-type answer format of five options.
after the intervention, 3 months corrected age

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2017

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

December 1, 2019

Study Registration Dates

First Submitted

October 9, 2017

First Submitted That Met QC Criteria

October 12, 2017

First Posted (Actual)

October 18, 2017

Study Record Updates

Last Update Posted (Actual)

December 9, 2019

Last Update Submitted That Met QC Criteria

December 6, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • PTNEO-001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Physical Therapy

Clinical Trials on Physical Therapy Early Intervention

3
Subscribe